About This Trial
This is a Phase 2 multicenter, randomized, double-blind, placebo-controlled, add-on to standard of care study of NBP softgel capsules for the treatment of mild to moderate AIS in adults.
- Status: Enrolling now
- Location: Miami Valley Hospital
- Study type: Interventional
- Ages eligible for study: 18 to 85
- Genders eligible for study: Both
- Principal Investigator: John Terry, M.D.
- For more information about this study, visit ClinicalTrials.gov: NCT02905565
If you would like information about participating in this study, contact:
Contact Us
Angela Shoen
937-208-6013
angela.shoen@wright.edu
asshoen@premierhealth.com